Literature DB >> 8514852

Protective protein gene mutations in galactosialidosis.

M Shimmoto1, Y Fukuhara, K Itoh, A Oshima, H Sakuraba, Y Suzuki.   

Abstract

Four different protective protein cDNA mutations, 146A-->G (Q49R), 193T-->C (W65R), 268-269TC-->CT (S90L), and 1184A-->G (Y395C), were identified in six Japanese galactosialidosis patients with various phenotypic manifestations, and another mutation, 746T-->A (Y249N), in a patient of French-German origin with an atypical clinical course. Y395C was a common mutation in four Japanese patients in infancy and childhood; two juvenile patients were compound heterozygotes of Y395C and another common mutation, SpDEx7, and the other two infants were compound heterozygotes of Y395C and mutant alleles other than SpDEx7. We confirmed these mutations in genomic DNA by direct-sequence analysis or restriction-site analysis. The mutant cDNA clones, transiently expressed in a transformed galactosialidosis cell line, did not restore the secondarily deficient beta-galactosidase or alpha-neuraminidase activity except for the Y249N mutation that expressed some carboxypeptidase activity and restored the two lysosomal enzyme activities. Pulse-chase analysis detected a small amount of the mature form, as well as the precursor, in the cells transfected with the Y249N cDNA. Only precursor proteins were detected, mature proteins not appearing for the other mutant cDNAs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514852      PMCID: PMC443297          DOI: 10.1172/JCI116472

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  14 in total

1.  Expression vector system based on the chicken beta-actin promoter directs efficient production of interleukin-5.

Authors:  J Miyazaki; S Takaki; K Araki; F Tashiro; A Tominaga; K Takatsu; K Yamamura
Journal:  Gene       Date:  1989-07-15       Impact factor: 3.688

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Macular cherry-red spots and myoclonus with dementia: coexistent neuraminidase and beta-galactosidase deficiencies.

Authors:  D A Wenger; T J Tarby; C Wharton
Journal:  Biochem Biophys Res Commun       Date:  1978-05-30       Impact factor: 3.575

4.  Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts.

Authors:  E Nanba; A Tsuji; K Omura; Y Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

5.  Expression of cDNA encoding the human "protective protein" associated with lysosomal beta-galactosidase and neuraminidase: homology to yeast proteases.

Authors:  N J Galjart; N Gillemans; A Harris; G T van der Horst; F W Verheijen; H Galjaard; A d'Azzo
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

6.  Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants.

Authors:  K Van Doren; Y Gluzman
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

7.  Galactosialidosis (beta-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of beta-galactosidase molecules.

Authors:  H Sakuraba; T Aoyagi; Y Suzuki
Journal:  Clin Chim Acta       Date:  1982-11-10       Impact factor: 3.786

8.  Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.

Authors:  F W Verheijen; S Palmeri; A T Hoogeveen; H Galjaard
Journal:  Eur J Biochem       Date:  1985-06-03

9.  Deficient lysosomal carboxypeptidase activity in galactosialidosis.

Authors:  J Tranchemontagne; L Michaud; M Potier
Journal:  Biochem Biophys Res Commun       Date:  1990-04-16       Impact factor: 3.575

10.  A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable.

Authors:  X Y Zhou; N J Galjart; R Willemsen; N Gillemans; H Galjaard; A d'Azzo
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  13 in total

1.  Molecular mechanism of lysosomal sialidase deficiency in galactosialidosis involves its rapid degradation.

Authors:  M V Vinogradova; L Michaud; A V Mezentsev; K E Lukong; M El-Alfy; C R Morales; M Potier; A V Pshezhetsky
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

2.  Cathepsin A is the major hydrolase catalyzing the intracellular hydrolysis of the antiretroviral nucleotide phosphonoamidate prodrugs GS-7340 and GS-9131.

Authors:  Gabriel Birkus; Ruth Wang; Xiaohong Liu; Nilima Kutty; Holly MacArthur; Tomas Cihlar; Craig Gibbs; Swami Swaminathan; William Lee; Martin McDermott
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

3.  Stable expression of protective protein/cathepsin A-green fluorescent protein fusion genes in a fibroblastic cell line from a galactosialidosis patient. Model system for revealing the intracellular transport of normal and mutated lysosomal enzymes.

Authors:  Y Naganawa; K Itoh; M Shimmoto; S Kamei; K Takiguchi; H Doi; H Sakuraba
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 4.  Chaperone-mediated autophagy in the kidney: the road more traveled.

Authors:  Harold A Franch
Journal:  Semin Nephrol       Date:  2013-11-22       Impact factor: 5.299

5.  The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis.

Authors:  G Rudenko; E Bonten; W G Hol; A d'Azzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

6.  Role of cathepsin A and lysosomes in the intracellular activation of novel antipapillomavirus agent GS-9191.

Authors:  Gabriel Birkus; Nilima Kutty; Christian R Frey; Riri Shribata; Tsuifen Chou; Carston Wagner; Martin McDermott; Tomas Cihlar
Journal:  Antimicrob Agents Chemother       Date:  2011-03-07       Impact factor: 5.191

7.  Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.

Authors:  A van der Spoel; E Bonten; A d'Azzo
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  Molecular mechanisms determining severity in patients with Pierson syndrome.

Authors:  Shogo Minamikawa; Saori Miwa; Tetsuji Inagaki; Kei Nishiyama; Hiroshi Kaito; Takeshi Ninchoji; Tomohiko Yamamura; China Nagano; Nana Sakakibara; Shingo Ishimori; Shigeo Hara; Norishige Yoshikawa; Daishi Hirano; Ryoko Harada; Riku Hamada; Natsuki Matsunoshita; Michio Nagata; Yuko Shima; Koichi Nakanishi; Hiroaki Nagase; Hiroki Takeda; Naoya Morisada; Kazumoto Iijima; Kandai Nozu
Journal:  J Hum Genet       Date:  2020-01-21       Impact factor: 3.172

9.  Intracellular processing and maturation of mutant gene products in hereditary beta-galactosidase deficiency (beta-galactosidosis).

Authors:  A Oshima; K Yoshida; K Itoh; R Kase; H Sakuraba; Y Suzuki
Journal:  Hum Genet       Date:  1994-02       Impact factor: 4.132

10.  Galactosialidosis: historic aspects and overview of investigated and emerging treatment options.

Authors:  Ida Annunziata; Alessandra d'Azzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-12-14       Impact factor: 0.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.